At the time of writing, Alx Oncology Holdings Inc [ALXO] stock is trading at $0.55, down -1.79%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ALXO shares have gain 14.58% over the last week, with a monthly amount drifted -28.73%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alx Oncology Holdings Inc [NASDAQ: ALXO] stock has seen the most recent analyst activity on March 06, 2025, when Jefferies upgraded its rating to a Buy and also boosted its price target to $3 from $2. Previously, Jefferies downgraded its rating to Hold on December 19, 2024, and dropped its price target to $2. On March 08, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $14 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $18 on December 08, 2023. Jefferies downgraded its rating to a Hold and reduced its price target to $25 on December 22, 2021. Stifel started tracking with a Buy rating for this stock on September 30, 2021, and assigned it a price target of $106.
For the past year, the stock price of Alx Oncology Holdings Inc fluctuated between $0.46 and $17.83. Currently, Wall Street analysts expect the stock to reach $1.5 within the next 12 months. Alx Oncology Holdings Inc [NASDAQ: ALXO] shares were valued at $0.55 at the most recent close of the market. An investor can expect a potential return of 172.73% based on the average ALXO price forecast.
Analyzing the ALXO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.91, Equity is -0.94 and Total Capital is -1.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5351 points at the first support level, and at 0.5201 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5709, and for the 2nd resistance point, it is at 0.5917.
Ratios To Look Out For
It is important to note that Alx Oncology Holdings Inc [NASDAQ:ALXO] has a current ratio of 7.26. In addition, the Quick Ratio stands at 7.26 and the Cash Ratio stands at 0.95.
Transactions by insiders
Recent insider trading involved Pinto Shelly, SVP, FINANCE AND CAO, that happened on Feb 19 ’25 when 550.0 shares were sold. PRESIDENT & CSO, Pons Jaume completed a deal on Feb 19 ’25 to sell 1326.0 shares. Meanwhile, CHIEF EXECUTIVE OFFICER Lettmann Jason sold 2159.0 shares on Feb 19 ’25.
